CTXR
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
17.1M
VYGR
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Jun 27 closing price
Capitalization
163.24M
32 days until earnings call
Interact to see
Advertisement

CTXR vs VYGR

Header iconCTXR vs VYGR Comparison
Open Charts CTXR vs VYGRBanner chart's image
Citius Pharmaceuticals
Price$1.33
Change-$0.00 (-0.00%)
Volume$26.95K
Capitalization17.1M
Voyager Therapeutics
Price$2.96
Change-$0.01 (-0.34%)
Volume$1.09M
Capitalization163.24M
CTXR vs VYGR Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. VYGR commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CTXR: $1.33 vs. VYGR: $2.96)
Brand notoriety: CTXR and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 1% vs. VYGR: 189%
Market capitalization -- CTXR: $17.1M vs. VYGR: $163.24M
CTXR [@Biotechnology] is valued at $17.1M. VYGR’s [@Biotechnology] market capitalization is $163.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than CTXR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • CTXR’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than VYGR.

Price Growth

CTXR (@Biotechnology) experienced а +23.15% price change this week, while VYGR (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($163M) has a higher market cap than CTXR($17.1M). VYGR YTD gains are higher at: -47.795 vs. CTXR (-66.750). CTXR has higher annual earnings (EBITDA): -42.77M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. CTXR (26.4K). CTXR has less debt than VYGR: CTXR (932K) vs VYGR (42M). VYGR has higher revenues than CTXR: VYGR (67M) vs CTXR (0).
CTXRVYGRCTXR / VYGR
Capitalization17.1M163M10%
EBITDA-42.77M-97.25M44%
Gain YTD-66.750-47.795140%
P/E RatioN/A6.32-
Revenue067M-
Total Cash26.4K236M0%
Total Debt932K42M2%
FUNDAMENTALS RATINGS
CTXR vs VYGR: Fundamental Ratings
CTXR
VYGR
OUTLOOK RATING
1..100
4979
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
3865
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (9) in the Pharmaceuticals Major industry is in the same range as VYGR (34) in the Biotechnology industry. This means that CTXR’s stock grew similarly to VYGR’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VYGR (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as CTXR (98) in the Pharmaceuticals Major industry. This means that VYGR’s stock grew similarly to CTXR’s over the last 12 months.

CTXR's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as VYGR (65) in the Biotechnology industry. This means that CTXR’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for CTXR (100) in the Pharmaceuticals Major industry. This means that VYGR’s stock grew significantly faster than CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXRVYGR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XIN1.76N/A
+0.28%
Xinyuan Real Estate Co Ltd
CFFI62.07-0.12
-0.19%
C&F Financial Corp
NNI120.56-0.74
-0.61%
Nelnet
CHPT0.74-0.02
-2.01%
ChargePoint Holdings
BBDO2.53-0.14
-5.24%
Banco Bradesco SA

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with EYEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then EYEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
N/A
EYEN - CTXR
36%
Loosely correlated
+39.99%
ALEC - CTXR
29%
Poorly correlated
-1.33%
KLTO - CTXR
29%
Poorly correlated
-42.39%
VYGR - CTXR
29%
Poorly correlated
-0.34%
ARVN - CTXR
28%
Poorly correlated
-3.14%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.34%
RGNX - VYGR
52%
Loosely correlated
-4.11%
TRDA - VYGR
52%
Loosely correlated
-1.57%
KYMR - VYGR
50%
Loosely correlated
-3.48%
XNCR - VYGR
48%
Loosely correlated
-3.10%
IMNM - VYGR
48%
Loosely correlated
-0.23%
More